BMED vs WDNA: Holdings Overlap & Returns

Over the year to Nov 13, 2026, BMED returned +25.4% to WDNA's +43.3%; 23% of their weight is in the same names.

Return gap
+17.9 pts1 year to Nov 13, 2026: WDNA ahead, total return
Fee gap
0.10 ptsA year: BMED 0.55%, WDNA 0.45%, per filings dated Nov 21, 2025 and Oct 28, 2026
Overlap
23%Share of the two books held in common, holdings dated Nov 12, 2026 and Jun 30, 2026
Net flow
–Needs daily flows for both funds
The answerOne drawing that carries it.

Compare two other funds

The evidenceWhy, in charts and cards.
BMED and WDNA · 1 year

Growth of 100

BMED +25.4%WDNA +43.3%
Growth of 100 in BMED and WDNA over 1 year, Nov 13, 2025 to Nov 13, 2026, with distributions reinvested. BMED ends at 125.4 (+25.4%), WDNA at 143.3 (+43.3%).

BMED +25.4%, WDNA +43.3%: WDNA +17.9 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.

Share

Use this comparison

Alert

BMED flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Hypothetical · drag the order size

Cost to trade

Hypothetical. A $10,000 order in BMED costs about $11.50 one way and $23.00 in and out, at a median spread of 0.23%. The 0.23% spread is BMED’s 30-day median, from iShares (fund page).

Hypothetical · drag to set

Fees over time

Hypothetical. $10,000 in BMED for 10 years at 0.55% a year costs about $908 in fees and lost growth; WDNA at 0.45% would cost $746. Assumes 6% a year before fees, a sample rate, not a forecast.

How each fund moved

BMED · 1 year to Nov 13, 202642% of its weight is outside the S&P 500
42% of its weight is outside the S&P 50058% of BMED's weight is in S&P 500 companies and 42% is outside the index. Holdings as of Nov 12, 2026.58%42%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 96% · top ten 44% of the fund · 55 holdings as published by its issuer for Nov 12, 2026 · Nasdaq-100: 14% in42% of its weight is outside the S&P 50058% of BMED's weight is in S&P 500 companies and 42% is outside the index. Holdings as of Nov 12, 2026.58%42%in the S&P 500outsideactive share 96% · Nasdaq-100: 14% in

58% of BMED's weight is in S&P 500 companies and 42% is outside the index. Holdings as of Nov 12, 2026.

WDNA · 1 year to Nov 13, 202674% of its weight is outside the S&P 500
74% of its weight is outside the S&P 50026% of WDNA's weight is in S&P 500 companies and 74% is outside the index. Holdings as of Jun 30, 2026.26%74%in the S&P 500of its weight outside the S&P 500active share 95% · top ten 31% of the fund · 80 holdings as filed for Jun 30, 2026 · Nasdaq-100: 5% in74% of its weight is outside the S&P 50026% of WDNA's weight is in S&P 500 companies and 74% is outside the index. Holdings as of Jun 30, 2026.26%74%inoutside the S&P 500active share 95% · Nasdaq-100: 5% in

26% of WDNA's weight is in S&P 500 companies and 74% is outside the index. Holdings as of Jun 30, 2026.

Key numbers

BMED in the S&P 500
58.2%
WDNA in the S&P 500
25.9%
BMED total return, 1 year
+25.4%
WDNA total return, 1 year
+43.3%

WDNA costs 0.10 points a year less; their one-year returns differ by 17.9 points.

Pair scorecard

Open the table

Points (pts) are percentage points.

Total return, 1 year+25.4%+43.3%
Below its all-time high13.9%, high on Sep 2, 2021
What it tracksHealthcare innovation and GLP-1Healthcare innovation and GLP-1
Expense ratio0.55%0.45%
Net assets, BMED as of Nov 13, 2026 and WDNA as of Jun 30, 2026$15m$2.7m
Holdings in common23%

The numbers behind it

Net assets: $15m on Nov 13, 2026 for iShares Health Innovation Active ETF, and $2.7m on Jun 30, 2026 for WisdomTree BioRevolution Fund.

Holdings in common uses holdings dated Jun 30, 2026 and Nov 12, 2026.

What they share

By the books each fund has filed, BMED and WDNA hold 23% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Nov 12, 2026.

0half (50%)100%

half

23% in common

Held in common

Show all 12 holdings
MODERNA5.52%4.14%
AMGEN INC2.57%1.54%
THERMO FISHER SCIENTIFIC4.33%1.52%
GILEAD SCIENCES5.80%1.51%
ROIVANT SCIENCES LTD1.42%1.73%
PFIZER1.46%1.34%
VERTEX PHARMACEUTICALS3.29%1.34%
NOVARTIS AG1.29%1.33%
JOHNSON & JOHNSON1.27%2.97%
ARGENX SE ADR1.87%0.94%
TEMPUS AI CLASS A0.91%2.28%
BIOGEN3.70%0.82%

Only in BMED

Show all 8 holdings
ABBVIE4.91%
EDWARDS LIFESCIENCES4.25%
METTLER-TOLEDO INTERNATIONAL INC3.61%
IQVIA HOLDINGS INC3.58%
ROCHE PS PAR AG2.85%
AGILENT TECHNOLOGIES INC2.34%
NEUROCRINE BIOSCIENCES2.31%
WATERS CORP2.25%

Only in WDNA

Show all 8 holdings
TWIST BIOSCIENCE CORP5.95%
ELI LILLY & COMPANY4.08%
UNITED THERAPEUTICS CORP2.45%
NATERA INC2.32%
IMMUNOME INC2.26%
STRUCTURE THERAPEUTICS INC2.12%
STOKE THERAPEUTICS INC2.09%
BEAM THERAPEUTICS INC2.09%

Side by side

Open the table
FundiShares Health Innovation Active ETF · Holds 55 stocks in healthcare innovation and GLP-1, 58% of its weight in S&P 500 companiesWisdomTree BioRevolution Fund · Holds 80 stocks in healthcare innovation and GLP-1, 26% of its weight in S&P 500 companies
IssueriSharesWisdomTree
ThemeHealthcare innovation and GLP-1Healthcare innovation and GLP-1
In the S&P 50058.2%25.9%
Active share vs the S&P 50095.6%95.3%
In the Nasdaq-10013.8%5.2%
Holdings5580
Top ten, share of the fund44.1%30.7%
Expense ratio0.55%0.45%
Fee for the differing part0.58%0.47%
Total return, 1 year+25.4%+43.3%
vs its benchmarknot measurednot measured
Below its high−2.7%−13.9%
Net assets, BMED as of Nov 13, 2026 and WDNA as of Jun 30, 2026$15m$2.7m

As of Nov 13, 2026. Source: ETFIQ.

Window by window

Open the table
3 months+12.9%+6.8%
6 months+33.6%+30.6%
1 year+25.4%+43.3%
3 years+68.1%+62.5%
Since launch (Not the same days: BMED Oct 2020 · WDNA Jun 2021)+42.8%−3.7%

About BMED

By weight, 58% of BMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 96%. The top ten holdings are 44% of the fund across 55 positions, as published by its issuer for Nov 12, 2026.

More

Over the year to Nov 13, 2026 the fund returned +25.4% with distributions reinvested.

About WDNA

By weight, 26% of WDNA's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 95%. The top ten holdings are 31% of the fund across 80 positions, as filed for Jun 30, 2026.

More

Over the year to Nov 13, 2026 the fund returned +43.3% with distributions reinvested. It sits 13.9% below its all-time high of Sep 2, 2021.

23% of the two portfolios are the same securities at the same weight.

Questions people ask

Do BMED and WDNA hold the same stocks?

By their latest filings, 23% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, BMED or WDNA?

BMED has 58% of its weight in S&P 500 names and WDNA has 26%, so BMED differs more from the index.

Which is cheaper, BMED or WDNA?

BMED charges 0.55% a year and WDNA charges 0.45%, so WDNA is cheaper. Fees come from each fund's prospectus.

Other comparisons

Sources

More

Links are sources, not endorsements. A comparison is not a recommendation.

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, BMED against WDNA, data as of Nov 13, 2026. https://etfiq.com/compare/themes/bmed-vs-wdna

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.